Cargando…
Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability
[Image: see text] Dipeptide monoester prodrugs of floxuridine were synthesized, and their chemical stability in buffers, resistance to glycosidic bond metabolism, affinity for PEPT1, enzymatic activation and permeability in cancer cells were determined and compared to those of mono amino acid monoes...
Autores principales: | Tsume, Yasuhiro, Hilfinger, John M., Amidon, Gordon L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2008
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659690/ https://www.ncbi.nlm.nih.gov/pubmed/18652477 http://dx.doi.org/10.1021/mp800008c |
Ejemplares similares
-
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
por: Tsume, Yasuhiro, et al.
Publicado: (2014) -
Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
por: Tsume, Yasuhiro, et al.
Publicado: (2008) -
The Feasibility of Enzyme Targeted Activation for Amino Acid/Dipeptide Monoester Prodrugs of Floxuridine; Cathepsin D as a Potential Targeted Enzym
por: Tsume, Yasuhiro, et al.
Publicado: (2012) -
Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine
por: Tsume, Yasuhiro, et al.
Publicado: (2017) -
Cytomegalovirus Protease Targeted Prodrug Development
por: Sabit, Hairat, et al.
Publicado: (2013)